Full Committee Hearing: Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)

Hearing

Date: Thursday, September 30, 2010 Time: 10:00 AM Location: HVC-210 Capitol Visitor Center

There was no video broadcast for this event.

Agenda

On Thursday, September 30, 2010, the Committee on Oversight and Government Reform held a hearing entitled, "Johnson & Johnson's Recall of Children's Tylenol and other Children's Medicines and the Phantom Recall of Motrin (Part 2)." This is the second hearing examining the circumstances surrounding the April 30, 2010, recall of more than 135 million bottles of Children's Tylenol and other popular pediatric medicines produced by Johnson & Johnson/McNeil Consumer Healthcare. The first hearing was held on May 27, 2010. This hearing will focus on both the broader recall announced in April of this year and on the "phantom recall" of an adult Motrin product that came to light as a result of the first hearing.

 

Witnesses

Witnesses

Panel I:

William C. Weldon
Chairman and Chief Executive Officer
Johnson & Johnson

Colleen Goggins
Worldwide Chairman, Consumer Group
Johnson & Johnson


Panel II:

Joshua M. Sharfstein, M.D.
Principal Deputy Commissioner
Food and Drug Administration (FDA)